Kevin Wayne Kuntz,Lorna Helen Mitchell,Gideon Shapiro,Richard Chesworth,Paula Ann Boriack-Sjodin
申请号：
US15276324
公开号：
US09868703B2
申请日:
2016.09.26
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds described herein are useful for inhibiting PRMT1 activity. Methods of using the compounds for treating PRMT1-mediated disorders are also described.
